Several clinical staging systems have been used in the past. The TNM (tumor, nodes, metastases) classification system developed by the American Joint Committee on Cancer (AJCC) is the most widely accepted classification system. TNM staging may use a combination of physical examination, positron emission tomography (PET), magnetic resonance imaging (MRI), and/or computed tomography (CT) to identify the primary tumor, involved nodes, and metastatic disease if present.

**AJCC 8th Edition:**

**Primary Tumor (T)**

- TX: Primary tumor not assessed

- T0: No evidence of primary tumor

- Tis: High-grade squamous intraepithelial lesion

- T1: Tumor 2 cm or less

- T2: Tumor more than 2 cm but not more than 5 cm

- T3: Tumor more than 5 cm

- T4: Tumor of any size that invades adjacent organ(s), including vagina, urethra, or bladder

**Regional Lymph Nodes (N)**

- NX: Regional lymph nodes cannot be assessed

- N0: No regional lymph node metastasis

- N1: Regional lymph node metastasis present

- N1a: Metastasis in inguinal, mesorectal, or internal iliac lymph nodes

- N1b: Metastasis in external iliac lymph nodes

- N1c: Metastasis in external iliac with any N1a nodes

**Distant Metastasis (M)**

- M0: No distant metastasis

- M1: Distant Metastasis

**Anatomic Stage/Prognostic Groups:**

- Stage 0:       Tis      N0        M0

- Stage I:        T1      N0        M0

- Stage IIA:     T2      N0        M0

- Stage IIB:     T3      N0        M0

- Stage IIIA:   T1-2    N1        M0

- Stage IIIB:   T4       N0        M0

- Stage IIIC:   T3-4    N1        M0

- Stage IV:     Any T  Any N   M1